Prof. Dr. AHMET ÇELİK
- Yöksis ID 46809
- Researcher ID 0000000294177610
- ORCID ID 0000000294177610
- Scopus ID
- Scholar ID
- E-posta ahmetcelik@mersin.edu.tr
- Dahili Telefon 21351
Birim
TIP FAKÜLTESİ
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
KARDİYOLOJİ ANABİLİM DALI
DAHİLİ TIP BİLİMLERİ BÖLÜMÜ
KARDİYOLOJİ ANABİLİM DALI
ÜAK Temel Alan Bilgisi
Sağlık Bilimleri Temel Alanı
Kardiyoloji
Kardiyoloji
Son 5 Makale
Vericiguat for patients with heart failure and reduced ejection fraction across the risk spectrum: an individual participant data analysis of the VICTORIA and VICTOR trials.
Lancet (London, England), vol. 406, no. 10510, pp. 1351– Link 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet (London, England), vol. 406, no. 10510, pp. 1341– Link 2025
Multimodality imaging in advanced heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Part 2: Mechanical circulatory support and heart transplantation
EUROPEAN JOURNAL OF HEART FAILURE, vol. 27, no. 11, pp. 2557–2570 Link 2025
The value of the HFA-PEFF and H2FPEF scores in determining the phenotypes and comorbidity burden in heart failure with preserved ejection fraction
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, vol. 45, no. 4, pp. – Link 2025
Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol. 14, no. 7, pp. – Link 2025
Lancet (London, England), vol. 406, no. 10510, pp. 1351– Link 2025
Vericiguat in patients with chronic heart failure and reduced ejection fraction (VICTOR): a double-blind, placebo-controlled, randomised, phase 3 trial.
Lancet (London, England), vol. 406, no. 10510, pp. 1341– Link 2025
Multimodality imaging in advanced heart failure. A clinical consensus statement of the Heart Failure Association of the ESC. Part 2: Mechanical circulatory support and heart transplantation
EUROPEAN JOURNAL OF HEART FAILURE, vol. 27, no. 11, pp. 2557–2570 Link 2025
The value of the HFA-PEFF and H2FPEF scores in determining the phenotypes and comorbidity burden in heart failure with preserved ejection fraction
CLINICAL PHYSIOLOGY AND FUNCTIONAL IMAGING, vol. 45, no. 4, pp. – Link 2025
Timing and Adherence Matter for Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure
JOURNAL OF THE AMERICAN HEART ASSOCIATION, vol. 14, no. 7, pp. – Link 2025
Son 5 Bildiri
Rapidly Progressive and Reversible Myocarditis after a Spider Bite
X. International Congress Of Update In Cardiology And Cardiovascular Surgery 2014 ( - )
Comparison of dapagliflozin 10 mg versus empagliflozin 10 mg in heart failure patients without type 2 diabetes mellitus on top of triple guideline-directed medical therapy
ESC HFA HEART FAILURE CONGRESS 2025 (17.05.2025 - 20.05.2025) Link 2025
Addition of sodium-glucose cotransporter-2 inhibitors on steroidal mineralocorticoid receptor antagonists eliminates hyperkalemia risk in diabetic heart failure patients with chronic kidney disease
ESC HFA HEART FAILURE 2025 CONGRESS (17.05.2025 - 20.05.2025) Link 2025
Impact of individual components of quadruple therapy in octagenerian heart failure patients: results from a real life data
ESC HFA Heart Failure 2025 Congress (17.05.2025 - 20.05.2025) Link 2025
Specific antidepressant effects among heart failure patients with depression: real life data
ESC HFA HEART FAILURE 2025 CONGRESS (17.05.2025 - 20.05.2025) Link 2025
X. International Congress Of Update In Cardiology And Cardiovascular Surgery 2014 ( - )
Comparison of dapagliflozin 10 mg versus empagliflozin 10 mg in heart failure patients without type 2 diabetes mellitus on top of triple guideline-directed medical therapy
ESC HFA HEART FAILURE CONGRESS 2025 (17.05.2025 - 20.05.2025) Link 2025
Addition of sodium-glucose cotransporter-2 inhibitors on steroidal mineralocorticoid receptor antagonists eliminates hyperkalemia risk in diabetic heart failure patients with chronic kidney disease
ESC HFA HEART FAILURE 2025 CONGRESS (17.05.2025 - 20.05.2025) Link 2025
Impact of individual components of quadruple therapy in octagenerian heart failure patients: results from a real life data
ESC HFA Heart Failure 2025 Congress (17.05.2025 - 20.05.2025) Link 2025
Specific antidepressant effects among heart failure patients with depression: real life data
ESC HFA HEART FAILURE 2025 CONGRESS (17.05.2025 - 20.05.2025) Link 2025